Immunosuppression and Clostridioides (Clostridium) difficile Infection Risk in Metabolic and Bariatric Surgery Patients

Immunosuppressant use increases risk of Clostridioides (Clostridium) difficile infection. To date, no studies have analyzed the relationship between immunosuppressant use and C  difficile infections after metabolic and bariatric surgery (MBS).

Source: Journal of the American College of Surgeons - May 17, 2021 Category: Surgery Authors: Elisa Morales-Marroquin, Luyu Xie, Madhuri Uppuluri, Jaime P. Almandoz, Nestor de la Cruz-Mu ñoz, Sarah E. Messiah Tags: Original scientific article Source Type: research